A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Purpose An optimal target for glucose control in ICU patients remains unclear. This prospective randomized controlled trial compared the effects on ICU mortality of intensive insulin therapy (IIT) with an intermediate glucose control. Methods Adult patients admitted to the 21 participating medico-surgical ICUs were randomized to group 1 (target BG 7.8-10.0 mmol/L) or to group 2 (target BG 4.4-6.1 mmol/L). Results While the required sample size was 1,750 per group, the trial was stopped early due to a high rate of unintended protocol violations. From 1,101 admissions, the outcomes of 542 patients assigned to group 1 and 536 of group 2 were analysed. The groups were well balanced. BG levels averaged in group 1 8.0 mmol/L (IQR 7.1-9.0) (median of all values) and 7.7 mmol/L (IQR 6.7-8.8) (median of morning BG) versus 6.5 mmol/L (IQR 6.0-7.2) and 6.1 mmol/L (IQR 5.5-6.8) for group 2 (p Conclusions In this prematurely stopped and therefore underpowered study, there was a lack of clinical benefit of intensive insulin therapy (target 4.4-6.1 mmol/L), associated with an increased incidence of hypoglycaemia, as compared to a 7.8-10.0 mmol/L target. (ClinicalTrials.gov # NCT00107601, EUDRA-CT Number: 200400391440).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A retrospective study suggested that tidal volumes should be lowered even with plateau pressures ≤ 30 cm H 2 O (431) because lower plateau pressures were associated with reduced hospital mortality (432).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [431]
In the citing paper
“In the surgical ICU, earlier studies have indicated that intensive glucose control (80 to 110 mg/dL) inconsistently resulted in decreased length of stay.94–96”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Intensive glycemic control post-operatively, compared to less intensive targets, has resulted in equivocal or mixed results; however, other studies have shown no benefits.94,100,101,104”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Obese patients are only slightly more prevalent in the ICU than in the hospital and in the related populations.”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
In the citing paper
“There is a large variability in the prevalence between countries with more than 39% and 37% obese (BMI>30 kg/m 2 ) present in the US ICUs and hospital wards, 22% and 19% in Europe, 17% and 14% in South America and 10% and 7% in the Asian and Pacific region based on data from the Nutrition Day project (6,351).”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiological and Chronic Health Evaluation (APACHE II) on admission [11] and the daily Sequential Organ Failure Assessment (SOFA) [12] scores and the presence of diabetes were recorded.”
MethodVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 9×
“The overall severity of organ failures assessed by daily SOFA scores were similar in both groups as were the other severity indices of illness, the number of febrile days and the number of days with anti-infective agents, except for the number of patient days with vasopressors/inotropes which was higher in the group 2…”
MethodInfluentialIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“Nevertheless, the mortality was slightly and not significantly increased in the group 2, consistently with other recent prospective trials [7, 14, 18, 19].”
ResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 9×
“The proportion of time in range calculated from morning BG values was not lower than in the most of the other studies [6, 7, 13, 17].”
BackgroundMethodResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Riker, R. R. (2009) · JAMA · doi:10.1001/jama.2009.56 · Cited by 1,672
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Self-citationKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165 · cited 1×
“with other recent findings [14, 25].”
Research works printed but not linked: 2
- Devos P, Preiser JC, Melot C (2007) Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med 33:S189
- Devos P, Ledoux D, Preiser JC (2005) Current practice of glycaemia control in European intensive care units (ICUS). Intensive Care Med 31:S203
Cited by
Items 401–500 of 912
Foubert, L. A., Lecomte, P. V., Nobels, F. R. E., Gulino, A. M., & Decker, K. H. D. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0082 · Cited by 14
Glucose Control in Mayo Clinic Intensive Care Units
Pattan, V., Parsaik, A. K., Brown, J. K., Kudva, Y. C., Vlahakis, N. E., & Basu, A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500613 · Cited by 14
McGrath, R. T., HOCKING, S. L., Priglinger, M. L., Day, S., Herkes, G., Krause, M., & Fulcher, G. R. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-008203 · Cited by 14
Glycemic control in acute illness
Egi, M., Furushima, N., Makino, S., & Mizobuchi, S. (2017) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2017.70.6.591 · Cited by 16
“The GLUCONTROL trial, a multicenter RCT (1,078 patients from 21 intensive care unit [ICUs] in Europe) [18], was stopped early due to a high incidence of protocol violations.”
BackgroundVogt, J. A., Wachter, U. A., Wagner, K., Calzia, E., Gröger, M., Weber, S., Stahl, B., Georgieff, M., Asfar, P., Fontaine, E. M., et al. (2014) · Intensive Care Medicine Experimental · doi:10.1186/2197-425x-2-19 · Cited by 17
“Finally, tight blood glucose control with insulin may lead to episodes of deleterious hypoglycemia [11,12].”
Self-citationBlood Sugar Targets in Surgical Intensive Care
Roth, J., Sommerfeld, O., Birkenfeld, A. L., Sponholz, C., Müller, U. A., & von Loeffelholz, C. (2021) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2021.0221 · Cited by 22
Malglycemia in the critical care setting. Part II: Relative and absolute hypoglycemia
Roberts, G., Krinsley, J. S., Preiser, J., Quinn, S. J., Rule, P. R., Brownlee, M., Umpierrez, G. E., & Hirsch, I. B. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154429 · Cited by 13
Self-citationA systematic review and meta-analysis on glycemic control in traumatic brain injury
García-Ballestas, E., Villafañe, J., Nuñez-Baez, K., Florez-Perdomo, W. A., Duran, M. A., Janjua, T. M., Moscote‐Salazar, L. R., & Agrawal, A. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108504 · Cited by 14
Prevention of renal dysfunction in postoperative elderly patients
Mårtensson, J., & Bellomo, R. (2014) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000107 · Cited by 13
“Tight glycemic control Preiser, 2009 [60] RCT Mixed Median age 65 years No effect on RRT requirement compared to blood glucose<10 mmol/l Postoperative problems”
BackgroundMethodResultBochicchio, G. V., Hipszer, B. R., Magee, M. F., Bergenstal, R. M., Furnary, A. P., Gulino, A. M., Higgins, M. J., Simpson, P. C., & Joseph, J. I. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815587939 · Cited by 14
“Numerous follow-up studies were unable to confirm the significant improvement in clinical outcome from intensive insulin therapy (IIT) and near-normal BG control reported by Van den Berghe.(47-54) The large prospective randomized NICE-SUGAR clinical trial reported that morbidity and mortality actually increased in the…”
ResultInfluentialForni, A. A., Rocchio, M. A., Szumita, P. M., Anger, K. E., Avery, K. R., & Scirica, B. M. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.01.002 · Cited by 15
Shan, L., Hao, P., & Chen, Y. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182250515 · Cited by 13
Improved safety with intravenous insulin therapy for critically ill patients with renal failure
Dickerson, R. N., Lynch, A. M., Maish, G. O., Croce, M. A., Minard, G., & Brown, R. O. (2013) · Nutrition · doi:10.1016/j.nut.2013.10.010 · Cited by 13
Gaies, M., Langer, M., Alexander, J. L., Steil, G. M., Ware, J., Wypij, D., Laussen, P. C., Newburger, J. W., Goldberg, C. S., Pigula, F. A., et al. (2012) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e31825b549a · Cited by 13
Aust, H., Dinges, G., Nardi-Hiebl, S., Koch, T., Lattermann, R., Schricker, T., & Eberhart, L. H. J. (2014) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2014.02.022 · Cited by 15
Hypoglycemia in sepsis: Biomarker, mediator, or both?*
Bellomo, R., & Egi, M. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822a5be5 · Cited by 13
Umbrello, M., Salice, V., Spanu, P., Formenti, P., Barassi, A., d’Eril, G. V. M., & Iapichino, G. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.10.007 · Cited by 13
Self-citationLlompart-Pou, J. A., Fernández-de-Castillo, A. G., Burguera, B. G., Pérez‐Bárcena, J., Marsé, P., Yago, M. Á. R., Barceló, A., & Raurich, J. M. (2012) · PubMed · doi:10.1590/s0212-16112012000100015 · Cited by 13
“However, recent multicenter trials have shown opposite results and in addition, raised concerns about the feasibility and indications for IIT.8-12 Specifically, safety was compromised by the increased incidence of hypoglycaemic episodes and significant glycaemic levels variability associated to insulin therapy, which…”
ResultInfluentialMazeraud, A., Polito, A., & Annane, D. (2014) · Critical Care · doi:10.1186/cc13998 · Cited by 13
“Whereas the Leuven trial demonstrated deleterious effects from uncontrolled glucose levels, subsequent trials comparing strategies to control BGL reported conflicting results [4,5,7-11].”
InfluentialSelf-citationJPEN Journal Club 11. Early Stopping
Koretz, R. L. (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114556318 · Cited by 13
Alizadeh, N., Khalili, H., Mohammadi, M., Abdollahi, M. R., & Ala, S. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12795 · Cited by 13
Singh, Y., Nakra, M., Verma, V., Shankar, K., Nachankar, A. S., & Kumar, K. V. S. (2017) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_105_17 · Cited by 13
“[4] The debate was laid to rest by NICE‐SUGAR study and the majority of the researchers now agree that good glycemic control is beneficial and intensive control may be useful in only select situations.[5,6] The controversy over the management of hyperglycemia in ICU extends beyond hyperglycemia into selecting the idea…”
BackgroundIntensive glucose control for critically ill patients: an updated meta-analysis
Fu, Y., Sun, Y., Zhang, J., & Cheng, Y. (2018) · Endocrine Connections · doi:10.1530/ec-18-0393 · Cited by 13
Treskes, N., Koekkoek, W. A. C., & van Zanten, A. R. H. (2018) · Shock · doi:10.1097/shk.0000000000001287 · Cited by 13
STAR-Liège Clinical Trial Interim Results: Safe and Effective Glycemic Control for All
Uyttendaele, V., Knopp, J. L., Pirotte, M., Morimont, P., Lambermont, B. C., Shaw, G. M., Desaive, T., & Chase, J. G. (2019) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2019.8856303 · Cited by 13
“However, GC has been proven hard to achieve safely, leading to increased blood glucose (BG) variability and risk of hypoglycemia [7-9], also independently associated with increased morbidity and mortality [9-11].”
BackgroundZabolotskikh, I. B., Кirov, М. Y., Лебединский, К. М., Николаевич, П. Д., Avdeev, S. N., Andreenko, A. A., Arsentev, L. V., Афончиков, В. С., Игоревич, А. И., Belkin, A. A., et al. (2022) · Annals of critical care · doi:10.21320/1818-474x-2022-1-5-140 · Cited by 13
Continuous glucose monitoring on the ICU using a subcutaneous sensor
Punke, M. A., Decker, C., Wodack, K., Reuter, D. A., & Kluge, S. (2015) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-014-0453-1 · Cited by 13
“Although the desired target glucose corridor has been shifted [2, 3], there is still strong focus on glucose control, underlined by the fact that there is a significant association between both hyperglycemia and hypoglycemia and mortality [4, 5, 6, 7].”
BackgroundNutrition Support Team‐Led Glycemic Control Program for Critically Ill Patients
Dickerson, R. N., Maish, G. O., Minard, G., & Brown, R. O. (2014) · Nutrition in Clinical Practice · doi:10.1177/0884533614530763 · Cited by 13
Ballesteros, D., Martínez-Nieto, Ó., Blancas, R., Parra, C. M., Matamala, B. L., Estebánez, B., & Chana, M. (2014) · Medicina Intensiva · doi:10.1016/j.medin.2014.09.004 · Cited by 13
Nutrition in the Intensive Care Unit: Year in Review 2008–2009
Taylor, B. E., & Krenitsky, J. (2010) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607109354900 · Cited by 17
Modelling insulin adsorption in intravenous infusion sets in the intensive care unit
Knopp, J. L., Hardy, A. R., Vergeer, S. L., & Chase, J. G. (2019) · IFAC Journal of Systems and Control · doi:10.1016/j.ifacsc.2019.100042 · Cited by 13
Cogle, S. V., Smith, S. E., Maish, G. O., Minard, G., Croce, M. A., & Dickerson, R. N. (2017) · Journal of Pharmacy and Nutrition Sciences · doi:10.6000/1927-5951.2017.07.03.6 · Cited by 13
Glucontrol, no control, or out of control?
Schultz, M. J., Spronk, P. E., & Houckgeest, F. V. B. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1666-2 · Cited by 13
“[1] are to be congratulated on their randomized controlled multi-center trial on tight glycemic control (TGC) in critically ill patients.”
BackgroundIntensive Control of Diabetes in the Hospital: Why, How, and What is in the Future?
Hsia, E., & Draznin, B. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500637 · Cited by 13
Roberts, G., Krinsley, J. S., Preiser, J., Quinn, S. J., Rule, P., Brownlee, M., Schwartz, M. W., Umpierrez, G., & Hirsch, I. B. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154327 · Cited by 12
Self-citation[Management of hyperglycemia in the hospitalized patient].
Pasquel, F. J., & Umpierrez, G. E. (2010) · PubMed · Cited by 19
Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes
Schwartz, S. S., DeFronzo, R. A., & Umpierrez, G. E. (2014) · Postgraduate Medicine · doi:10.1080/00325481.2015.996504 · Cited by 12
“Results from the Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis study (VISEP) [11], Glucontrol [12], Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE-Sugar) [13], and other trials [14] have found no benefit or even increased mortality/morbidity in…”
MethodSugiyama, Y., Wakabayashi, R. H., Urasawa, M., Maruyama, Y., Shimizu, S., & Kawamata, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0140 · Cited by 12
The Long and Winding Road to Personalized Glycemic Control in the Intensive Care Unit
Tickoo, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1697603 · Cited by 12
Perioperative management of blood glucose during open heart surgery in infants and children
Steven, J. M., & Nicolson, S. C. (2011) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2011.03587.x · Cited by 13
Glucose control in critically ill patients
Flower, O. J., & Finfer, S. R. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02631.x · Cited by 13
Effects of Hyperglycemia and Continuous Intravenous Insulin on Outcomes of Surgical Patients
Schlussel, A. T., Holt, D. B., Crawley, E. A., Lustik, M. B., Wade, C. E., & UYEHARA, C. F. T. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.07.004 · Cited by 13
Glycemic Variability and Glycemic Control in the Acutely Ill Cardiac Patient
Moore, J., & Dungan, K. M. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.006 · Cited by 14
Ulate, K. P. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e318207097e · Cited by 12
“However, as the compelling results of the initial Leuven trials began to cause a shift in standard of care practice in ICUs, it altered the definition of conventional glucose management for each institution and effectively changed the control group to which large trials have compared strict glycemic control (9, 10).”
ResultDiabetes and the Cardiovascular System
McGuire, D. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00064-0 · Cited by 14
van Steen, S. C. J., Rijkenberg, S., van der Voort, P. H. J., & DeVries, J. H. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0507-x · Cited by 14
Utility of bedside artificial pancreas for postoperative glycemic control in cardiac surgery
Urai, S., Naoko, H., Takabe, M., Yuya, K., Satake, Y., Nishimoto, Y., Motoharu, K., Henmi, S., Kuroda, M., Yamane, Y., et al. (2020) · Journal of Artificial Organs · doi:10.1007/s10047-020-01223-7 · Cited by 12
Zabolotskikh, I. B., Кirov, М. Y., Лебединский, К. М., Николаевич, П. Д., Avdeev, S. N., Andreenko, A. A., Arsentev, L. V., Афончиков, В. С., Игоревич, А. И., Belkin, A. A., et al. (2021) · Annals of critical care · doi:10.21320/1818-474x-2021-s1-9-143 · Cited by 14
Evidence based evaluation of immuno-coagulatory interventions in critical care.
Afshari, A. (2011) · PubMed · Cited by 13
Paddle, J., Eve, R., & Sharpe, K. A. (2011) · Anaesthesia · doi:10.1111/j.1365-2044.2010.06603.x · Cited by 12
Gestion de la glycémie : un audit dans 66 réanimations
Orban, J., Scarlatti, A., Lefrant, J., Molinari, N., Léone, M., Jaber, S., Constantin, J.-M., Allaouchiche, B., & Ichaï, C. (2013) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2012.12.002 · Cited by 12
Hospital hypoglycemia: From observation to action
Bellam, H., & Braithwaite, S. S. (2010) · Insulin · doi:10.1016/s1557-0843(10)80007-7 · Cited by 13
Krinsley, J. S., & Preiser, J. (2010) · Critical Care · doi:10.1186/cc9275 · Cited by 14
Self-citationMukherjee, J. J., Chatterjee, P., Saikia, M., Muruganathan, A., & Das, A. K. (2014) · PubMed · Cited by 18
Uyttendaele, V., Knopp, J. L., Pirotte, M., Guiot, J., Morimont, P., Lambermont, B. C., Shaw, G. M., Desaive, T., & Chase, J. G. (2018) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2018.11.614 · Cited by 12
“However, others have shown glycaemic control (GC) hard to reproduce safely, with significantly increased risk of hypoglycaemia for no reductions in mortality (Brunkhorst et al., 2008; Finfer et al., 2009; Finfer et al., 2012; Preiser et al., 2009).”
BackgroundRisk and reward: extending stochastic glycaemic control intervals to reduce workload
Uyttendaele, V., Knopp, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2020) · BioMedical Engineering OnLine · doi:10.1186/s12938-020-00771-6 · Cited by 13
Turck, C. J., Frazee, E., Kram, B., Daley, M. J., Day, S. A., Horner, D., Lesch, C. A., Mercer, J. M., Plewa-Rusiecki, A. M., & Herout, P. M. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp130303 · Cited by 12
Krinsley, J. S., Rule, P., Brownlee, M., Roberts, G., Preiser, J., Chaudry, S., Dionne, K., Heluey-Rodrigues, C., Umpierrez, G. E., & Hirsch, I. B. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211032277 · Cited by 11
“1494 Journal of Diabetes Science and Technology 16(6)”
BackgroundSelf-citationPreoperative HbA1c and Outcomes following Lower Extremity Vascular Procedures
Buelter, J., Smith, J. B., Carel, Z. A., Kinsey, D., Kruse, R. L., Vogel, T. R., & Bath, J. (2021) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2021.12.002 · Cited by 11
Critical Illness Hyperglycemia in Pediatric Cardiac Surgery
Ulate, K. P., Raj, S. S., & Rotta, A. T. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600105 · Cited by 11
Joseph, J. I., Torjman, M. C., & Strasma, P. J. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815587938 · Cited by 13
Tight Glucose Control versus Intermediate Glucose Control: A Quasi-Experimental Study
Durão, M. S., Marra, A. R., Moura, D. F., de Almeida, S. M., Fernandes, C. J. C. D. S., Akamine, N., Hidal, J. T., & dos Santos, O. F. P. (2010) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1003800309 · Cited by 11
Koyfman, L., Brotfain, E., Erblat, A., Kovalenko, I., Reina, Y.-Y., Bichovsky, Y., Borer, A., Friger, M., Frenkel, A., & Klein, M. (2018) · Anaesthesiology Intensive Therapy · doi:10.5603/ait.2018.0004 · Cited by 11
Yuan, Q., Liu, H., Xu, Y., Wu, X., Sun, Y., & Hu, J. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9730-0 · Cited by 11
Rooyackers, O., Blixt, C., MATTSSON, P., & Wernerman, J. (2012) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2012.02787.x · Cited by 11
“Two subsequent studies, in a medical and a pediatric ICU, confirmed this observation,(2,3) whereas others did not.(4,5) The largest study actually showed the opposite effect.”
ResultSelf-citationPérez-Calatayud, Á. A., Guillén-Vidaña, A., Fraire-Félix, I. S., Malagón, E. D. A., Garduño, J. C. B., & Carrillo-Esper, R. (2017) · Cirugía y Cirujanos (English Edition) · doi:10.1016/j.circen.2016.10.005 · Cited by 11
Roberts, G. W., Krinsley, J. S., Preiser, J., Quinn, S. J., Rule, P. R., Brownlee, M., Umpierrez, G. E., & Hirsch, I. B. (2024) · Journal of Critical Care · doi:10.1016/j.jcrc.2024.154537 · Cited by 10
Self-citationReview of Insulin Therapy and Pen Use in Hospitalized Patients
Davis, E. M., Foral, P. A., Dull, R. B., & Smith, A. N. (2013) · Hospital Pharmacy · doi:10.1310/hpj4805-396 · Cited by 10
Taking the Septic Patient to the Operating Room
Hofer, J. E., & Nunnally, M. (2010) · Anesthesiology Clinics · doi:10.1016/j.anclin.2010.01.005 · Cited by 10
Safe and Effective Use of a Glycemic Control Protocol for Neonates in a Cardiac ICU*
Hebson, C. L., Chanani, N. K., Rigby, M. R., Wolf, M. J., Deshpande, S. R., Montegna, L. M., & Maher, K. (2013) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e31827200de · Cited by 10
Hypoglycemia Reduction Strategies in the ICU
Braithwaite, S. S., Bavda, D. B., Idrees, T., Qureshi, F. M., & Soetan, O. T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0963-3 · Cited by 13
Tian, Y., Wang, R., Zhang, M., Li, T., He, Y., & Wang, R. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.12.007 · Cited by 10
Controle glicêmico em terapia intensiva 2009: sem sustos e sem surpresas
Pitrowsky, M. T., Righy, C., Soares, M., & Salluh, J. I. (2009) · Revista Brasileira de Terapia Intensiva · doi:10.1590/s0103-507x2009000300012 · Cited by 10
Lleva, R. R., Thomas, P. G., Bozzo, J., Hendrickson, K. C., & Inzucchi, S. E. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814540871 · Cited by 10
Wagstaff, A. E., & Cheung, N. W. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0444-2 · Cited by 11
Fernández‐Méndez, R., Harvey, D., Windle, R. J., & Adams, G. G. (2019) · Journal of Clinical Nursing · doi:10.1111/jocn.14774 · Cited by 10
“Insulin resistance in critically ill patients often requires that insulin is administered in very high concentrations for its effect to saturate, which in turn increases the risk for iatrogenic hypoglycaemia (Preiser et al., 2009).”
BackgroundPractical implications of the revised guidelines for inpatient glycemic control
Reider, J. A., Donihi, A. C., & Korytkowski, M. T. (2009) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.847 · Cited by 11
Characterizing Glucose Changes Antecedent to Hypoglycemic Events in the Intensive Care Unit
Cook, C. B., Potter, D. J., & Kongable, G. L. (2011) · Endocrine Practice · doi:10.4158/ep11215.or · Cited by 10
Are closed-loop systems for intensive insulin therapy ready for prime time in the ICU?
Okabayashi, T., & Shima, Y. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000026 · Cited by 11
Luethi, N., Cioccari, L., Eastwood, G. M., Biesenbach, P., Morgan, R., Sprogis, S. K., Young, H., Peck, L., Chong, C. K., Moore, S., et al. (2019) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13354 · Cited by 10
Anane, Y., Szlávecz, Á., Knopp, J. L., Razak, N. N. A., Abu-Samah, A., Shaw, G. M., Chase, J. G., & Benyó, B. I. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211018260 · Cited by 10
Wu, Y., Pei, J., Yang, X., Cheng, Z.-D., Zhao, Y., & Xiang, B. (2013) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2012.10.003 · Cited by 10
“Interventions to control high blood glucose may be necessary to improve clinical outcomes, as shown by various trials in both children and adults [16–18].”
MethodAspekte der perioperativen Behandlung von Diabetespatienten
Pestel, G., Closhen, D., Zimmermann, A., Werner, C. D., & Weber, M. (2012) · Der Anaesthesist · doi:10.1007/s00101-012-2089-y · Cited by 10
Ward, L., Steel, J., Compte, A. L., Evans, A., Tan, C.-S., Penning, S., Shaw, G. M., Desaive, T., & Chase, J. G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600115 · Cited by 11
“Hence, compliance has been problematic in TGC and can significantly affect results [11, 20, 21].”
BackgroundBeyond diabetes: harnessing the power of metformin in burn care
Khalaf, F., Touma, D., Saldanha, S., Khalaf, G., Barayan, D., & Jeschke, M. G. (2025) · Critical Care · doi:10.1186/s13054-025-05662-7 · Cited by 9
Yu, G., Ma, H., Lv, W., Zhou, P., & Liu, C. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13662 · Cited by 10
Understanding Glycemic Control in the Critically Ill: 2011 Update
Krinsley, J. S. (2011) · Hospital Practice · doi:10.3810/hp.2011.04.394 · Cited by 9
Schwartz, S. S., & DeFronzo, R. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0466-9 · Cited by 9
Knab, T. D., Clermont, G., & Parker, R. S. (2015) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2015.09.099 · Cited by 9
Ammar, M. A., Ammar, A. A., Wee, T., Deshpande, R. P., Band, M., & Akhtar, S. (2022) · Journal of Intensive Care Medicine · doi:10.1177/08850666221098383 · Cited by 9
“However, subsequent studies were unable to show similar results.(4,5) A major, randomized, multicenter study (NICE-SUGAR) reported significant mortality risk associated with intensive insulin targets establishing the widely adopted conservative guideline of maintaining glucose levels around 140-180 mg/dL.”
ResultInfluentialControle glicêmico em pacientes críticos na UTI
Silva, W. O. (2013) · Revista Hospital Universitário Pedro Ernesto · doi:10.12957/rhupe.2013.7530 · Cited by 9
Glycemic Control in the Pediatric Intensive Care Unit of Leuven: Two Years of Experience
Herpe, T. V., Vanhonsebrouck, K., Mesotten, D., Moor, B. D., & den Berghe, G. V. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600103 · Cited by 10
Glucose Control in the ICU: Is There a Time for More Ambitious Targets Again?
Haluzík, M., Mráz, M., Kopecký, P., Lipš, M., & Svacina, S. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814533847 · Cited by 11
“However, some other trials questioned safety, reproducibility and universality of beneficial effects of tight glycemic control (TGC) in other subgroups of critically ill patients, leading consequently to a shift toward a more conservative approach to glucose lowering in ICU settings in the last years.(17,18) The resul…”
ResultMaury, É., Vitry, P., Galbois, A., Ait‐Oufella, H., Baudel, J.-L., Guidet, B., & Offenstadt, G. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-16 · Cited by 9
“It also is intriguing to note that reports of large multicenter, randomized, controlled trials assessing the impact of IIT make no mention of the tubing system used [1-4,12].”
BackgroundInfluentialCONSIDERACIONES FARMACOLÓGICAS GENERALES Y PARTICULARES EN CUIDADOS INTENSIVOS
Regueira, T. (2016) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2016.09.008 · Cited by 9
“Lo que a su vez fue confirmado por otros estudios posteriores (21).”
BackgroundData Entry Errors and Design for Model-Based Tight Glycemic Control in Critical Care
Ward, L., Steel, J., Compte, A. L., Evans, A., Tan, C.-S., Penning, S., Shaw, G. M., Desaive, T., & Chase, J. G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600116 · Cited by 10
“Achieving a high level of compliance is vital to the success of a clinical protocol [26, 27].”
BackgroundHow Low Should You Go? The Limbo of Glycemic Control in Intensive Care Units
Faust, A. C., Attridge, R. L., & Ryan, L. (2011) · Critical Care Nurse · doi:10.4037/ccn2011188 · Cited by 10
Strilka, R. J., Stull, M. C., Clemens, M. S., McCaver, S. C., & Armen, S. B. (2016) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-016-0029-2 · Cited by 9
“In general, TGC studies have been plagued by frequent hypoglycemia [22, 24] and worsened mortality [25].”
BackgroundA “Virtual Patient” Cohort and Mathematical Model of Glucose Dynamics in Critical Care
Knab, T. D., Clermont, G., & Parker, R. S. (2016) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2016.12.094 · Cited by 9
Evaluation of a continuous blood glucose monitoring system using central venous microdialysis
Möller, F., Liška, J., & Franco‐Cereceda, A. (2011) · Critical Care · doi:10.1186/cc9825 · Cited by 9
Metadata
- Authors
- Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., Wernerman, J., Joannidis, M., Stecher, A., & Chioléro, R.
- Affiliations
- Centre Hospitalier Universitaire de Liège (BE)
- Erasmus Hospital (BE)
- Hôpital Raymond-Poincaré (FR)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Milan (IT)
- Université Joseph Fourier (FR)
- Institut Gustave Roussy (FR)
- Rabin Medical Center (IL)
- Karolinska Institutet (SE)
- Universität Innsbruck (AT)
- Ljubljana University Medical Centre (SI)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Preiser, Jean-Charles
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2009-07-28
- Volume
- 35
- Issue
- 10
- Pages
- 1738-1748
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2139706988
- Cited by
- 911
- References
- 37
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 24 · 2023: 33 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 57 · 2015: 69 · 2014: 80 · 2013: 76 · 2012: 95
- FWCI
- 75.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Universidad de Las Palmas de Gran Canaria
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, tight glycemic control, glycemic targets, critically ill adults, intensive care unit, ICU mortality, hypoglycemia, insulin therapy, early trial termination, protocol violations, time in target glucose range, ICU length of stay, cost-effectiveness, quality of life
- MeSH terms
- Aged, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Male, Middle Aged, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.